首页|期刊导航|中国临床药理学杂志|熊果苷调控Notch1/Hes1通路对缺氧/复氧诱导的心肌细胞损伤影响的研究

熊果苷调控Notch1/Hes1通路对缺氧/复氧诱导的心肌细胞损伤影响的研究OA

The effect of arbutin on hypoxia/reoxygenation induced myocardial cell injury by modulating the Notch1/Hes1 pathway

中文摘要英文摘要

目的 探讨熊果苷调控缺刻基因1(Notch1)/发状分裂相关增强子1(Hes1)通路对缺氧/复氧(H/R)诱导的心肌细胞(H9C2)损伤的影响.方法 将H9C2细胞分为正常组、模型组、低、中、高剂量实验组(25.00、50.00、100.00 μmoL·L1的熊果苷)、抑制剂组{100.00 μmoL·L-1的熊果苷+10.00 μmoL·L-1 N-[N-(3,5-二氟苯乙酰基)-L-丙氨酰]-S-苯基甘氨酸叔丁酯(DAPT)}.正常组常规培养,其余各组均建立H/R诱导的H9C2细胞损伤模型,各给药组于造模前分别给予不同浓度熊果苷(12.50~200.00 μmoL·L-1)预处理24 h.细胞计数(CCK-8)法与原位末端凋亡(TUNEL)分别检测细胞增殖与凋亡,JC-1法测线粒体膜电位,试剂盒检测活性氧(ROS)、乳酸脱氢酶(LDH)、谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)、超氧化物歧化酶(SOD)水平,蛋白质印迹法检测Notch1、Hes1、凋亡相关B淋巴细胞瘤2(Bcl-2)、Bcl-2相关X蛋白(Bax)、半胱天冬氨酸蛋白酶3(caspase-3)蛋白表达.结果 25.00~200.00 μmoL·L-1的熊果苷能够显著增加H/R诱导的H9C2细胞存活率(P<0.05),选择25.00、50.00、100.00 μmoL·L-1的熊果苷作为低、中、高剂量进行后续实验.正常组、模型组、高剂量实验组、抑制剂组的肌酸激酶-MB(CK-MB)水平分别为(2.45±0.39)、(8.72±0.82)、(3.56±0.42)和(5.48±0.57)U·mL-1;心肌肌钙蛋白I(cTnI)水平分别为(22.58±2.23)、(68.34±5.96)、(30.12±3.26)和(49.62±5.15)ng·L-1;LDH 水平分别为(53.42±5.44)、(163.72±13.41)、(65.45±6.57)和(98.33±9.85)U·L-1;ROS 相对水平分别为 1.01±0.12、3.34±0.35、1.46±0.18 和 2.24±0.23;SOD 水平分别为(96.23±8.12)、(24.31±2.24)、(78.39±7.93)和(43.78±4.49)U·mg-1;GSH-Px 水平分别为(74.82±7.55)、(16.42±1.83)、(61.32±6.29)和(35.72±3.38)U·mg-1;MDA 水平分别为(15.45±2.03)、(58.33±5.57)、(21.56±2.24)和(42.47±4.13)μmol·L-1;细胞凋亡率分别为(2.45±0.39)%、(29.86±3.25)%、(9.86±0.91)%和(21.34±2.25)%;红/绿荧光强度比值分别为(5.78±0.65)%、(1.42±0.20)%、(4.89±0.54)%和(2.85±0.33)%;Notch1 蛋白表达分别为 1.27±0.12、0.34±0.03、1.05±0.08和 0.54±0.05;Hes1 蛋白表达分别为 0.95±0.10、0.25±0.03、0.81±0.08 和0.57±0.05;Bel-2 蛋白表达分别为 1.01±0.11、0.31±0.03、0.89±0.08 和0.61±0.06;Bax 蛋白表达分别为 0.45±0.04、1.34±0.12、0.61±0.06 和0.93±0.09;caspase-3 蛋白表达分别为 0.23±0.03、0.91±0.09、0.37±0.04 和0.64±0.06;正常组与模型组比较、模型组与低、中、高剂量实验组比较、高剂量实验组与抑制剂组比较,上述指标在统计学上均有统计学意义(均P<0.05).结论 熊果苷通过激活Notch1/Hes1通路,抑制氧化应激,减轻H/R诱导的H9C2细胞损伤.

Objective To investigation the effect of arbutin on hypoxia/reoxygenation(H/R)-induced injury of cardiomyocytes(H9C2)through the neurogenic locus notch homolog protein 1(Notch 1)/hairy and enhancer of split 1(Hes1)signaling pathway.Methods An H/R-induced H9C2 cell injury model was established.The optimal intervention concentration of arbutin was screened by pretreating cells with various concentrations(12.50-200.00μmol·L-1).H9C2 cells were divided into a normal group,a model group,experimental-L,M,H groups(25.00,50.00,and 100.00 μmol·L-1 arbutin,respectively),and an inhibitor group { 100.00 μmol·L-1 arbutin+10.00μmol·L-1N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester(DAPT)}.Cells in the normal group were cultured under normal conditions,while H/R models were established in the remaining groups.All treatment groups received arbutin pretreatment at concentrations ranging from 12.50 to 200.00 μmol·L-1 for 24 hours before modeling.Cell proliferation was detected by the CCK-8 assay,and apoptosis was assessed by TUNEL assay;mitochondrial membrane potential was measured by JC-1;reactive oxygen species(ROS),lactate dehydrogenase(LDH),glutathione peroxidase(GSH-Px),malondialdehyde(MDA),and superoxide dismutase(SOD)levels were detected using kits.Expression of Notch1,Hes1,Bcl-2,Bax,and caspase-3 was detected by Western blot.Results Arbutin at concentrations of 25.00-200.00 μmol·L-1 significantly increased the survival rate of H/R-induced H9C2 cells(P<0.05).Arbutin at 25.00,50.00,and 100.00 μmol·L-1 was selected as the low,medium,and high doses for subsequent experiments.The creatine kinase isoenzyme MB(CK-MB)levels in the normal group,model group,experimental-H group,and inhibitor group were(2.45±0.39),(8.72±0.82),(3.56±0.42),and(5.48±0.57)U·mL-1,respectively;the cTnI levels were(22.58±2.23),(68.34±5.96),(30.12±3.26),and(49.62±5.15)ng·L-1,respectively;the LDH levels were(53.42±5.44),(163.72±13.41),(65.45±6.57),and(98.33±9.85)U·L-1,respectively;the relative ROS levels were 1.01±0.12,3.34±0.35,1.46±0.18,and 2.24±0.23,respectively;the SOD levels were(96.23±8.12),(24.31±2.24),(78.39±7.93),and(43.78±4.49)U·mg-1,respectively;the GSH-Px levels were(74.82±7.55),(16.42±1.83),(61.32±6.29),and(35.72±3.38)U·mg-1,respectively;the MDA levels were(15.45±2.03),(58.33±5.57),(21.56±2.24),and(42.47±4.13)μmol·L-1,respectively;the apoptosis rates were(2.45±0.39)%,(29.86±3.25)%,(9.86±0.91)%,and(21.34±2.25)%,respectively;the red/green fluorescence intensity ratios were(5.78±0.65)%,(1.42±0.20)%,(4.89±0.54)%,and(2.85±0.33)%,respectively;the Notch1 protein expression levels were 1.27±0.12,0.34±0.03,1.05±0.08,and 0.54±0.05,respectively;the Hes1 protein expression levels were 0.95±0.10,0.25±0.03,0.81±0.08,and 0.57±0.05,respectively;the Bcl-2 protein expression levels were 1.01±0.11,0.31±0.03,0.89±0.08,and 0.61±0.06,respectively;the Bax protein expression levels were 0.45±0.04,1.34±0.12,0.61±0.06,and 0.93±0.09,respectively;and the caspase-3 protein expression levels were 0.23±0.03,0.91±0.09,0.37±0.04,and 0.64±0.06,respectively.Comparisons between the normal group and the model group,between the model group and the experimental-L,M,H groups,and between the experimental-H group and the inhibitor group all showed statistically significant differences for the above indicators(all P<0.05).Conclusion Arbutin alleviates H/R-induced H9C2 cell injury by activating the Notch1/Hes1 pathway and inhibiting oxidative stress.

陈红芬;吕孝欣;张玉清

山东第二医科大学附属医院心血管内一科,山东潍坊 261031山东第二医科大学附属医院心血管内一科,山东潍坊 261031山东第二医科大学附属医院心血管内一科,山东潍坊 261031

医药卫生

熊果苷缺氧/复氧缺刻基因1/发状分裂相关增强子1通路心肌细胞损伤

arbutinhypoxia/reoxygenationneurogenic locus notch homolog protein 1/hairy and enhancer of split 1 pathwaymyocardial cell injury

《中国临床药理学杂志》 2026 (7)

947-953,7

山东省重点研发计划基金资助项目(2023-YBSF-015)

10.13699/j.cnki.1001-6821.2026.07.008

评论